Claudio Morales-Perez, a protein production scientist at Generate:Biomedicines, with one of the company's four cryogenic electron microscopes (Studio Nouveau, Lara Woolfson)

Ex­clu­sive: The se­cret to de­sign­ing pro­tein drugs with AI? Gen­er­ate be­lieves it's cryo-EM at un­prece­dent­ed scale

One of the lead­ing biotech com­pa­nies us­ing ar­ti­fi­cial in­tel­li­gence to de­sign pro­tein-based drugs is bet­ting that suc­cess lies not in more com­put­ing pow­er, but in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA